HomeInsightsStock Comparison

Accretion Pharmaceuticals Ltd vs Norris Medicines Ltd Stock Comparison

Accretion Pharmaceuticals Ltd vs Norris Medicines Ltd Stock Comparison

Last Updated on: Jun 06, 2025

Key Highlights

  • The Latest Trading Price of Accretion Pharmaceuticals Ltd is ₹ 65.4 as of 06 Jun 15:42.
  • The P/E Ratio of Accretion Pharmaceuticals Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Norris Medicines Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The Market Cap of Accretion Pharmaceuticals Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Norris Medicines Ltd changed from ₹ 2.81 crore on March 2020 to ₹ 13.6 crore on March 2024 . This represents a CAGR of 37.08% over 5 years.
  • The revenue of Accretion Pharmaceuticals Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Norris Medicines Ltd for the Mar '25 is ₹ 2.77 crore as compare to the Dec '24 revenue of ₹ 1.11 crore. This represent the growth of 149.55%.
  • The ebitda of Accretion Pharmaceuticals Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Norris Medicines Ltd for the Mar '25 is ₹ 0.12 crore as compare to the Dec '24 ebitda of ₹ -0.02 crore. This represent the decline of -700%.
  • The net profit of Accretion Pharmaceuticals Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of Norris Medicines Ltd changed from ₹ -0.61 crore to ₹ -0.23 crore over 8 quarters. This represents a CAGR of -38.60% .
  • The Dividend Payout of Accretion Pharmaceuticals Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Norris Medicines Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Accretion Pharmaceuticals Ltd

  • Accretion Pharmaceuticals was incorporated in year 2012, the Promoters Mr. Harshad Nanubhai Rathod, Mr. Vivek Ashok Kumar Patel, Mr. Mayur Popatlal Sojitra and Mr. Hardik Mukundbhai Prajapati, came together to establish a pharmaceutical manufacturing unit, to provide health care products.
  • Thus, the foundation of 'Accretion Pharmaceuticals' was laid down, which was started as a Partnership Firm in the name of 'M/s Accretion Pharmaceuticals', pursuant to a deed of partnership dated December 18, 2012. The manufacturing facility which is currently located at Ahmedabad, in Sanand District of Gujarat, commenced its manufacturing operations in year 2014.
  • Thereafter, the Partnership Firm was converted into a Limited Company in the name of 'Accretion Pharmaceuticals Limited' and a certificate of incorporation dated November 29, 2023 was issued by the Registrar of Companies, Central Registration Centre, for and on behalf of the jurisdictional Registrar of Companies.

About Norris Medicines Ltd

  • Norris Medicines Limited was established in September, 1990 as a small scale unit at GIDC Estate, Ankleshwar to manufacture non sterile dosage e.g. tablets, capsules, Liquid Orals, Copical ointments.
  • The Company was subsequently converted into Public Limited Company on March 7, 1992.
  • The unit expanded to manufacture Sterile dosage in form of Ampoules & Vials. The Company got into the business in the year 1990.
  • Commercial production of the formulation unit commenced in Nov.'91.
  • The production unit expanded to manufacture Sterile dosage in form of Ampoules & Vials.

Accretion Pharmaceuticals Ltd News Hub

News

Accretion Pharmaceuticals to discuss results

Accretion Pharmaceuticals will hold a meeting of the Board of Directors of the Company on ...

Read more

05 Jun 2025 10:16

News

NSE SME Accretion Pharma stumbles on market debut

The scrip was listed at 79, a discount of 21.78% over the initial public offer (IPO) price...

Read more

21 May 2025 10:38

News

NSE SME Accretion Pharmaceuticals' IPO ends with subscription of 7.31 times

The initial public offer (IPO) of Accretion Pharmaceuticals received bids for 2,00,06,400 ...

Read more

19 May 2025 11:43

Norris Medicines Ltd News Hub

News

Norris Medicines to discuss results

Norris Medicines will hold a meeting of the Board of Directors of the Company on 28 May 20...

Read more

24 May 2025 18:27

News

Norris Medicines to declare Quarterly Results

Norris Medicines will hold a meeting of the Board of Directors of the Company on 13 Februa...

Read more

11 Feb 2025 10:43

News

Norris Medicines to table results

Norris Medicines will hold a meeting of the Board of Directors of the Company on 14 Novemb...

Read more

12 Nov 2024 11:24

News

Norris Medicines to conduct AGM

Norris Medicines announced that the 33th Annual General Meeting (AGM) of the company will ...

Read more

16 Sep 2024 13:58

News

Norris Medicines to discuss results

Norris Medicines will hold a meeting of the Board of Directors of the Company on 14 August...

Read more

09 Aug 2024 16:52

News

Norris Medicines to discuss results

Norris Medicines will hold a meeting of the Board of Directors of the Company on 29 May 20...

Read more

25 May 2024 19:21

SWOT Analysis Of Norris Medicines Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Norris Medicines Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of null and Norris Medicines Ltd

Which company has a larger market capitalization, Accretion Pharmaceuticals Ltd or Norris Medicines Ltd?

Market cap of Accretion Pharmaceuticals Ltd is 71 Cr while Market cap of Norris Medicines Ltd is 19 Cr

What are the key factors driving the stock performance of Accretion Pharmaceuticals Ltd and Norris Medicines Ltd?

The stock performance of Accretion Pharmaceuticals Ltd and Norris Medicines Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Accretion Pharmaceuticals Ltd and Norris Medicines Ltd?

As of June 6, 2025, the Accretion Pharmaceuticals Ltd stock price is INR ₹64.1. On the other hand, Norris Medicines Ltd stock price is INR ₹19.43.

How do dividend payouts of Accretion Pharmaceuticals Ltd and Norris Medicines Ltd compare?

To compare the dividend payouts of Accretion Pharmaceuticals Ltd and Norris Medicines Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions